NP Pulse: The Voice of the Nurse Practitioner (AANP)

Don’t miss the Signs: Early Recognition and Management of Tardive Dyskinesia

In this episode, Amber Hoberg and Dr. Jennifer Sampang bring us an engaging discussion on the complexities of tardive dyskinesia, the significance of early detection and treatment, and the considerable burden it has on patients. As they unwind the mysteries of TD, we get a better understanding of the importance of being vigilant and proactive in detecting it and keeping our patients informed and involved in their treatment plans. Together, through early recognition, informed discussions, and shared decision-making, we can mitigate the impact of TD and improve the lives of those affected. Additionally, a Tardive Dyskinesia Point-of-Care tool will be available on AANP’s Tools and Resources page.

To earn 1.0 contact hours of continuing education (CE) credit, you will need the participation code provided at the end of the podcast. To claim your CE credit, log in and register for the activity within the AANP CE Center log in and register for the activity within the AANP CE Center, then enter the participation code and complete the posttest and evaluation. CE credit is available for this podcast through August 2025.

This educational activity is supported by an independent medical education grant from Neurocrine Biosciences, Inc.

Nurse practitioners Sharon Fruh and Angie Golden provide insight and tips for health care providers to help patients combating obesity better deal with stress that might otherwise complicate treatment.

This episode is sponsored by an educational grant from Novo Nordisk, Inc.

AANP speaks with experts in diabetes care to get their first-hand experiences, expertise and tips for health care providers to best meet the needs of their patients.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

The third entry in the 2020 NP Week series, NPs Moving Forward: Today. Tomorrow. Together., features NP pioneer Dr. Jan Towers. Dr. Towers was pivotal in laying the groundwork for the advancement of the NP role and in large part responsible for the formation of the American Association of Nurse Practitioners.

Sickle cell disease (SCD) is a condition of immense and multifarious clinical gravity causing acute pain, joint damage, anemia and risk of infection, stroke, delayed growth in children and adolescents — as well as long-term organ dysfunction. However, recent evolutions in treatment options offer promising novel and emerging therapeutics poised to truly revolutionize SCD care. On this episode of NP Pulse: The Voice of the Nurse Practitioner®, nurse practitioner (NP) specialists Sheryl Mitchell and Artangela Henry guide NPs to achieve the following learning objectives:

• Describe the epidemiologic patterns, pathophysiologic principles and robust patient burden of SCD.
• Examine current best practices for SCD diagnosis, highlighting the fundamental importance of early disease detection, characterization and linkage to treatment.
• Evaluate the established and evolving therapeutic landscape for SCD, with a focus on recent regulatory approvals and emerging trial data for novel agents.
• Design individualized, evidence-driven treatment plans for patients with SCD that mitigate disease complications and improve quality of life.
• Identify residual unmet needs in the SCD treatment paradigm and discuss the role of ongoing research and comprehensive, multidisciplinary care strategies in closing these gaps.

This program and the accompanying clinical resource tool were made possible by a medical education grant from Vertex.

Continuing education (CE) credit for this program may be claimed through Dec. 31, 2025. To claim credit for this program, log in to the CE Center, search for this program by name and complete the post-test and evaluation by entering the participation code that is given after listening to the podcast.